144.34
Icu Medical Inc stock is traded at $144.34, with a volume of 366.51K.
It is up +4.37% in the last 24 hours and up +1.18% over the past month.
ICU Medical is a California-based pure-play infusion therapy company that provides consumables, systems, and services for virtually every component of the IV continuum of care. ICU has become one of the largest players in its industry following its acquisition of Hospira Infusion Systems from Pfizer in 2017 and Smiths Medical from Smiths Group in 2022. It holds top-tier positions across its three reporting segments: consumables (43% of consolidated revenue), infusion systems (28%), and vital care (29%). The combined entity remains primarily US-focused, generating over 63% of its sales domestically.
See More
Previous Close:
$138.30
Open:
$145.24
24h Volume:
366.51K
Relative Volume:
1.31
Market Cap:
$3.35B
Revenue:
$2.34B
Net Income/Loss:
$-111.01M
P/E Ratio:
-31.58
EPS:
-4.57
Net Cash Flow:
$159.53M
1W Performance:
+6.13%
1M Performance:
+1.18%
6M Performance:
-18.91%
1Y Performance:
+34.77%
Icu Medical Inc Stock (ICUI) Company Profile
Name
Icu Medical Inc
Sector
Industry
Phone
949-366-2183
Address
951 CALLE AMANECER, SAN CLEMENTE, CA
Compare ICUI with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
![]()
ICUI
Icu Medical Inc
|
144.34 | 3.35B | 2.34B | -111.01M | 159.53M | -4.57 |
![]()
ISRG
Intuitive Surgical Inc
|
561.43 | 190.61B | 8.71B | 2.48B | 1.75B | 6.82 |
![]()
ALC
Alcon Inc
|
94.79 | 48.17B | 9.91B | 1.02B | 665.00M | 2.05 |
![]()
BDX
Becton Dickinson Co
|
175.34 | 47.86B | 20.87B | 1.50B | 2.59B | 5.24 |
![]()
RMD
Resmed Inc
|
247.66 | 35.29B | 5.02B | 1.31B | 1.56B | 8.91 |
![]()
COO
The Cooper Companies, Inc.
|
84.44 | 16.31B | 3.90B | 392.30M | 288.10M | 1.95 |
Icu Medical Inc Stock (ICUI) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Mar-12-25 | Upgrade | Raymond James | Outperform → Strong Buy |
Dec-11-24 | Upgrade | Jefferies | Hold → Buy |
Oct-14-24 | Initiated | Jefferies | Hold |
Jun-21-24 | Initiated | Needham | Hold |
Jun-17-24 | Upgrade | Raymond James | Mkt Perform → Outperform |
Nov-08-22 | Downgrade | Raymond James | Outperform → Mkt Perform |
Mar-31-20 | Upgrade | CJS Securities | Market Perform → Market Outperform |
Mar-18-20 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
Aug-08-19 | Downgrade | Raymond James | Strong Buy → Outperform |
Oct-17-17 | Initiated | KeyBanc Capital Mkts | Sector Weight |
Jun-20-17 | Downgrade | Sidoti | Buy → Neutral |
Mar-11-16 | Initiated | Gabelli & Co | Buy |
Nov-06-15 | Reiterated | ROTH Capital | Buy |
Aug-11-15 | Reiterated | ROTH Capital | Buy |
May-06-15 | Reiterated | ROTH Capital | Buy |
Feb-10-15 | Reiterated | ROTH Capital | Buy |
Nov-11-14 | Upgrade | ROTH Capital | Neutral → Buy |
May-09-13 | Downgrade | The Benchmark Company | Buy → Hold |
Sep-27-12 | Reiterated | The Benchmark Company | Buy |
Apr-12-12 | Initiated | The Benchmark Company | Buy |
Sep-26-11 | Reiterated | Ticonderoga | Buy |
Oct-29-09 | Initiated | C.K. Cooper | Buy |
Oct-08-09 | Initiated | Roth Capital | Hold |
Mar-05-09 | Initiated | Northland Securities | Outperform |
May-02-08 | Initiated | Jesup & Lamont | Buy |
Mar-26-08 | Initiated | Soleil | Buy |
View All
Icu Medical Inc Stock (ICUI) Latest News
When (ICUI) Moves Investors should Listen - news.stocktradersdaily.com
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ICU Medical, Inc.ICUI - PR Newswire
Solventum, Envista, ICU Medical, Globus Medical, and Enovis Stocks Trade Up, What You Need To Know - FinancialContent
Raymond James Cuts ICU Medical (NASDAQ:ICUI) Price Target to $187.00 - Defense World
ICU Medical, Inc. (NASDAQ:ICUI) Just Reported And Analysts Have Been Cutting Their Estimates - simplywall.st
ICU Medical (NASDAQ:ICUI) Shares Gap Down Following Analyst Downgrade - Defense World
ICU Medical, Inc. (NASDAQ:ICUI) Q1 2025 Earnings Call Transcript - Insider Monkey
ICU Medical (ICUI) Maintains Strong Buy Rating Amid PT Adjustmen - GuruFocus
ICU Medical (NASDAQ:ICUI) Stock Rating Lowered by StockNews.com - Defense World
ICU Medical (ICUI) Sees Price Target Adjustment Amid Strong Q1 R - GuruFocus
ICUI Q1 Earnings Call: Product Upgrades and Tariff Headwinds Shape Outlook - Yahoo Finance
ICU Medical (ICUI) Maintains Strong Buy Rating Amid PT Adjustment | ICUI Stock News - GuruFocus
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against ICU Medical, Inc. (ICUI) And Encourages Shareholders to Reach Out - ACCESS Newswire
ICU Medical price target lowered to $187 from $197 at Raymond James - TipRanks
ICU Medical Surpasses Revenue Expectations in Q1 2025News and Statistics - IndexBox
ICU Medical Q1 2025 slides: revenue up 8% as joint venture transaction looms - Investing.com
ICU Medical Inc (ICUI) Q1 2025 Earnings Call Highlights: Strong Revenue Growth Amid Tariff ... - Yahoo Finance
ICU Medical Q1 Adjusted Earnings, Revenue Increase - marketscreener.com
Earnings call transcript: ICU Medical Q1 2025 sees earnings beat, stock jumps - Investing.com
ICU Medical Reports Strong Q1 2025 Revenue Growth - TipRanks
ICU Medical: Q1 Earnings Snapshot - The Washington Post
Decoding ICU Medical Inc (ICUI): A Strategic SWOT Insight - GuruFocus
Bragar Eagel & Squire, P.C. Is Investigating RobinHood, - GlobeNewswire
ICU MEDICAL Earnings Results: $ICUI Reports Quarterly Earnings - Nasdaq
ICU Medical (ICUI) Q1 Earnings and Revenues Beat Estimates - Yahoo Finance
ICU Medical Inc reports results for the quarter ended March 31Earnings Summary - TradingView
ICU Medical (NASDAQ:ICUI) Delivers Impressive Q1 - Yahoo Finance
ICU Medical Q1 Loss Narrows As Revenue Rises 7% - Nasdaq
ICU Medical Inc Q1 2025 Earnings: Revenue Surpasses Estimates at $604.7 Million, GAAP EPS Misses at $(0.63) - GuruFocus
Earnings Flash (ICUI) ICU Medical Posts Q1 Revenue $604.7M, vs. FactSet Est of $588.4M - marketscreener.com
ICU Medical Announces First Quarter 2025 Results - The Manila Times
Infusion Pumps Market Analysis: Data-Driven Insights - openPR.com
Bragar Eagel & Squire, P.C. Is Investigating RobinHood, Aldeyra, Landstar, and ICU Medical ... - Bluefield Daily Telegraph
Earnings To Watch: ICU Medical Inc (ICUI) Reports Q1 2025 Result - GuruFocus
ICU Medical, Inc. (NASDAQ:ICUI) Shares Sold by First Trust Advisors LP - Defense World
What To Expect From ICU Medical’s (ICUI) Q1 Earnings - Yahoo Finance
ICU MEDICAL SECURITIES INVESTIGATION: Kaplan Fox & Kilsheimer LLP is Investigating ICU Medical, Inc. (ICUI) for Possible Securities Law Violations - The Globe and Mail
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of ICU Medical, ... - Bluefield Daily Telegraph
Intravenous Solutions Market Projected To Witness Massive - openPR.com
Bronstein, Gewirtz & Grossman, LLC Encourages ICU Medical, Inc. (ICUI) Stockholders to Inquire about Securities Investigation - Louisiana First News
ICUI SHAREHOLDER ALERT: Kaplan Fox & Kilsheimer LLP is Investigating ICU Medical, Inc. (ICUI) for Potential Securities Law Violations | FinancialContent - FinancialContent
ICU Medical (ICUI) Q4 Earnings Report Preview: What To Look For - The Globe and Mail
(ICUI) Investment Report - news.stocktradersdaily.com
ICU Medical (NASDAQ:ICUI) Upgraded by StockNews.com to “Buy” Rating - Defense World
Press Release Distribution & PR Platform - ACCESS Newswire
ICU Medical, Otsuka Pharmaceutical Factory Form IV Joint Venture - marketscreener.com
ICU Medical, Inc. and Otsuka Pharmaceutical Factory, Inc. Comple - GuruFocus
ICU Medical, Inc. and Otsuka Pharmaceutical Factory, Inc. Complete Joint Venture to Bolster IV Solutions Manufacturing and Innovation in North America | ICUI Stock News - GuruFocus
ICU Medical, Inc. and Otsuka Pharmaceutical Factory, Inc. Complete Joint Venture to Bolster IV Solutions Manufacturing and Innovation in North America - Stock Titan
3 Reasons ICUI is Risky and 1 Stock to Buy Instead - Yahoo Finance
ICU Medical (ICUI) to Release Earnings on Thursday - Defense World
Icu Medical Inc Stock (ICUI) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):